Botanisol analytics has developed the world’s first autonomous disease screening kiosk, which can be integrated into airport checkin and facilities access workflows. It provides 96% accurate results in under 60 seconds. CEO Dave Talenfeld is a serial life science entrepreneur who’s raised nearly $20,000,000, not including a $22,000,000 exit by acquisition to a NYSE listed company.